Advancements in the development of radiopharmaceuticals for nuclear medicine applications in the treatment of bone metastases
MR Dyer, Z Jing, K Duncan, J Godbe… - Nuclear Medicine and …, 2024 - Elsevier
Bone metastases are a painful and complex condition that overwhelmingly impacts the
prognosis and quality of life of cancer patients. Over the years, nuclear medicine has made …
prognosis and quality of life of cancer patients. Over the years, nuclear medicine has made …
Novel agents and future perspectives on theranostics
In the current era of precision medicine, there is renewed interest in radiopharmaceutical
therapy and theranostics. The approval of somatostatin receceptor directed therapy and …
therapy and theranostics. The approval of somatostatin receceptor directed therapy and …
[HTML][HTML] Peptide receptor radionuclide therapy implementation and results in a predominantly gastrointestinal neuroendocrine tumor population: A two-year …
A Mejia, E Vivian, C Nwogu, J Shah, R Longoria, A Vo… - Medicine, 2022 - journals.lww.com
Neuroendocrine tumors (NETs) are rare, but the incidence and prevalence of NETs are
increasing in the United States. While surgery is the preferred treatment for NETs, it is not a …
increasing in the United States. While surgery is the preferred treatment for NETs, it is not a …
Realising the potential of radioligand therapy: policy solutions for the barriers to implementation across Europe
C Merkel, CH Whicher, J Bomanji, K Herrmann… - European Journal of …, 2020 - Springer
Background The use of targeted radiation with radioisotopes has been applied for decades
in thyroid cancer. However, the use of radioligand therapy—also referred to as peptide …
in thyroid cancer. However, the use of radioligand therapy—also referred to as peptide …
Evaluation of radiation safety of the newly established national New Zealand 177–Lutetium (177-Lu or Lutate) Peptide Receptor Radiation Therapy (PRRT) service, a …
J Davidson, A Hull, T Mead, B Lunt, A Stewart - Journal of Medical Imaging …, 2022 - Elsevier
Following the initiation of a fortnightly interim National service in New Zealand for PRRT, for
6 months, radiation safety measurements over several hours during the treatment were …
6 months, radiation safety measurements over several hours during the treatment were …
[PDF][PDF] POUR LE DIPLOME D'ETUDES SPECIALISEES DE PHARMACIE HOSPITALIERE ET DES COLLECTIVITES
ML Sidi-Mohamed - 2021 - pepite-depot.univ-lille.fr
Le médicament radiopharmaceutique (MRP) est défini par l'article L5121-1 du Code de la
santé publique (CSP) comme «tout médicament qui, lorsqu'il est prêt à l'emploi, contient un …
santé publique (CSP) comme «tout médicament qui, lorsqu'il est prêt à l'emploi, contient un …
[引用][C] Evaluation of Lu-177 radiotherapy applications based on Monte Carlo simulations
Α Κλωτσοτύρα - 2020